FARMINGTON, CT & PHILADELPHIA, PA — Torigen Pharmaceuticals is making strides in veterinary medicine by employing Proscia’s ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...

As the CEO of Karyon Bio, Thirunagari introduced the company’s ground breaking Digital Liver initiative, an AI-powered ...

Thainakarin Hospital has announced its readiness to provide services at the Thainakarin Precision Oncology Center (TPOC), one ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Culina Health was founded to address the need for affordable and accessible nutrition counseling. The company's telehealth ...

A new artificial intelligence model developed by Stanford Medicine combines clinical notes and pathology images to predict ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...